STAR STI Group Assesses Multi-drug-resistant Gonorrhea Infections
The vice president of SSS’ Clinical Research and Biosciences group, Anthony Cristillo, is the first author of an article in Sexually Transmitted Diseases that summarizes a meeting convened by the Sexually Transmitted Infections Clinical Trial Group on antimicrobial resistance in Neisseria gonorrhoeae, the bacteria that causes gonorrhea. SSS, as the clinical operations partner in the Group, assembled experts from academia, government, non-profits, and industry to discuss the current state of research, gaps and challenges in research and technology, and priorities and new directions to address the continued emergence of multi-drug-resistant gonorrhea infections. Other authors of the article include researchers from the University of California San Diego, Centers for Disease Control and Prevention, University of Saskatchewan, Charles R. Drew University of Medicine and Sciences, University of California Los Angeles, Harvard University T.H. Chan School of Public Health, University of North Carolina at Chapel Hill, University of Massachusetts Medical School, Entasis Therapeutics, Cempra, Emory University School of Medicine, Duke University Medical Center, and the World Health Organization.
Read more about SSS research activities in our online publication SSS Update.